CLINICAL_TRIALS
trial_result
· 2025-03-13
Clinical Trial Update: Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis [Phase 4]
Summary
Phase 4 trial update showing efficacy and safety of deucravacitinib versus placebo in adults with moderate-to-severe scalp psoriasis, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2025-03-13